—Mkt Cap: —P/E: —
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with…
Industry Peers
Health Care Technologyloading…
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value19.51M USD
Revenue (TTM)0 USD
Gross Profit-1.48M USD
Net Income (TTM)-14.14M USD
Revenue/Share0.0000 USD
Last Price—
Fiscal Year EndMar 2023
MR QuarterDec 2023
Employees36
CountryUS
SectorHealth Care
IndustryHealth Care Technology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA-1.73
EV/Revenue—
P/SInfinity
P/B-0.00
EPS (TTM)-0.39
EPS (Forward)-0.44
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin-1916.30%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-18358.00%
ROE119.72%
ROA-97.12%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.45M USD
CapEx (TTM)539.22K USD
FCF Margin—
FCF Yield—
Net Debt19.51M USD
Net Debt/EBITDA-1.73
Balance Sheet
Debt/Equity-1.70
Current Ratio0.19
Quick Ratio0.02
Book Value/Sh-0.6170 USD
Cash/Share0.0050 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 5, 2019
Splits
Last Split1:10
Split DateDec 5, 2019
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.40.35M
Float12.43M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.3d
Short % Float0.31%
Short % Out.0.18%
Shares Short52.57K
Short (prev mo.)192.20K
Technical
SMA 500.0002 USD
SMA 2000.0001 USD
Beta-116.46
S&P 52W Chg28.31%
Avg Vol (30d)—
Avg Vol (10d)60
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—